Eventide Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-609,014	Closed	-$31.1M	–	227
2024 Q4	$31.1M	Sell	609,014 -126,074	-17%	-$7.05M	0.57%	62
2024 Q3	$37.6M	Hold	735,088	–	–	0.65%	52
2024 Q2	$32.9M	Sell	735,088 -324,545	-31%	-$15M	0.56%	58
2024 Q1	$49.6M	Hold	1,059,633	–	–	0.78%	46
2023 Q4	$37.7M	Buy	1,059,633 +40,851	+4%	+$1.25M	0.62%	56
2023 Q3	$30.3M	Buy	1,018,782 +584,014	+134%	+$12M	0.54%	55
2023 Q2	$7.83M	Hold	434,768	–	–	0.13%	124
2023 Q1	$6.98M	Buy	+434,768	New	+$8.05M	0.13%	124
2021 Q2	–	Sell	-241,140	Closed	-$3.69M	–	154
2021 Q1	$3.69M	Sell	241,140 -158,860	-40%	-$2.46M	0.05%	139
2020 Q4	$5.64M	Sell	400,000 -947,000	-70%	-$13.2M	0.09%	123
2020 Q3	$21.1M	Hold	1,347,000	–	–	0.41%	71
2020 Q2	$23.6M	Buy	1,347,000 +400,000	+42%	+$6.82M	0.51%	63
2020 Q1	$13.9M	Hold	947,000	–	–	0.45%	67
2019 Q4	$23.8M	Hold	947,000	–	–	0.67%	59
2019 Q3	$14.2M	Buy	947,000 +143,161	+18%	+$2.78M	0.47%	67
2019 Q2	$20.1M	Buy	803,839 +419,839	+109%	+$10.4M	0.61%	60
2019 Q1	$8.74M	Buy	384,000 +260,775	+212%	+$6.41M	0.3%	75
2018 Q4	$3.7M	Hold	123,225	–	–	0.16%	92
2018 Q3	$3.53M	Buy	+123,225	New	+$3.66M	0.13%	106